On Tuesday, July 28th, we held a town meeting to update the cancer center community on progress in Smilow Cancer Hospital and introduce the clinical leadership teams.
The list below indicates those individuals who will be responsible for organizing the transition of multispecialty care to Smilow. We anticipate that not every clinic will be exactly the same - one size does not fit all - however, we are committed to ensuring that each disease program meets the needs of its patients and promotes multidisciplinary care whenever possible.
If you have general questions or concerns, please feel free to provide your feedback to Peter Marks. For disease specific concerns, please contact the individual team leaders.
As the number of daily workers within Smilow Cancer Hospital increases to over 450, the hospital and contractor are revising the tour polices to continue to ensure both a safe and productive work environment. For this reason, general building tours have been put on hold until a new policy is implemented. We will advise when the general tours will resume shortly.
Questions can be directed to David Vinas, Transition Leader, at 688-2973.
The Biomedical Informatics Shared Resource provides informatics support to Yale Cancer Center Research Programs through close integration with other major Biomedical Informatics research, development, and educational activities at Yale School of Medicine.
Services provided by the Resource include: informatics support of YCC clinical research and electronic data capture (EDC) for clinical trial data (TrialDB) and tissue (caTISSUE).
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.